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Despite Clostridium difficile infection (CDI) being a common cause of diarrhoea in hos-
pitals worldwide, diagnostic testing or management guidelines are not available in most
hospitals in China. In this prospective two-year study, the incidence of CDI among 276
patients with watery diarrhoea was 23.1%. Lack of diagnostic testing for CDI was associ-
ated with improper management in 26.4% of patients, risk of nosocomial transmission from
lack of isolation precautions, and risk of community transmission from discharging
symptomatic toxigenic C. difficile carriers. Updating practice guidelines in line with the
current evidence and implementing diagnostic testing for CDI are recommended in hos-
pitals in China.
ª 2016 The Authors. Published by Elsevier Ltd
on behalf of The Healthcare Infection Society. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Clostridium difficile infection (CDI) is widely recognized as
one of the most common hospital-acquired infections. CDI hasent of Microbiology and
esearch Unit, Shantou
Technology Building, 22
.R. China. Tel./fax: þ86
williambathein@alumni.
Elsevier Ltd on behalf of The
ivecommons.org/licenses/by-led to high mortality, heavy health burden and increased
healthcare costs.1 Timely and appropriate management of CDI
and specific infection control measures, including isolation
precautions and environmental disinfection, are recommended
to reduce transmission.2
Despite the growing health concerns around the world, CDI
remains a neglected disease in China.3 Most Chinese hospitals
do not perform diagnostic testing for CDI routinely, and hence
the incidence of CDI in China is not known.4 Moreover, CDI is not
included in the infection control guidelines published by the
Chinese Health Ministry,5 which is currently the standardHealthcare Infection Society. This is an open access article
nc-nd/4.0/).
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hospitals.
This study aimed to investigate the incidence of CDI and
associated clinical burden from lack of diagnostic testing in a
tertiary Chinese hospital.Methods
This prospective study was undertaken at a tertiary, 1800-
bedded, teaching hospital in Shantou, Guangdong Province over
two years (November 2012eNovember 2014). This study was
approved by the ethics committee of the participating hospital
and Oxford University Tropical Research Ethical Committee.
Patients who experienced at least three episodes of watery
diarrhoea or unformed stool (Bristol Stool Scale types 6 and 7)6
in 24 h for at least one day were provisionally diagnosed with
CDI and recruited into the study. Single faecal samples were
collected from each patient and tested for CDI in three steps:
standard microbiological screening [anaerobically cultured on
to blood agar and cefoxitin-cycloserine fructose agar plates
(Oxoid, Basingstoke, UK) for 48 to 72 h], 16S-polymerase chain
reaction (PCR) and toxin-PCR, as described previously.7
Statistical analyses were conducted using Statistical Pack-
age for the Social Sciences Version 21 (IBM Corp., Armonk, NY,
USA), with a two-tailed P<0.05 taken to indicate significance.Table I
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CDI, Clostridium difficile infection.
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Among 276 patients who were provisionally diagnosed with
CDI as the primary admission diagnosis (community-acquired)
or secondary diagnosis (hospital-acquired within 48 h of
admission) in 15 clinical departments (Table I), 23.1% (63/276)
were positive for toxigenic Clostridium-difficile (TCD), car-
rying tcdA, tcdB or both. TCD-positive cases included
community-acquired CDI (34.9%, 22/63) and hospital-acquired
CDI (65.1%, 41/63).
Among the CDI cases, only 15.9% (10/63) received the rec-
ommended antibiotics for CDI (metronidazole and/or vanco-
mycin), and half of the cases (5/10) became chronic (decrease
in stool consistency for more than four weeks). The other cases
(84.1%, 53/63) received up to seven types of antibiotics not
recommended for CDI, and 18.9% (10/53) remained symptom-
atic or chronic (data not shown).
Among the non-CDI cases, 9.4% (20/213) received metroni-
dazole or vancomycin, and diarrhoea did not resolve in 30% of
these cases (6/20) during the study period (data not shown).Discussion
This is the first report from China about the clinical burden
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acid amplification test or GDH enzyme immunoassay (EIA)-toxin
test8 because EIA test kits were not available locally.
The incidence rates of total CDI (23.1%, 63/276),
community-acquired CDI (8.0%, 22/276) and hospital-onset
CDI (15.1%, 41/276) in this study were similar to a report
from Shanghai,9 but much lower than those from other
developed countries, such as the USA and UK.10,11 Although
the incidence of CDI can vary with the diagnostic ap-
proaches employed in different studies, with higher inci-
dence rates associated with detection of toxin genes by
PCR, the likely reason behind lower incidence in China could
be under-diagnosis from lack of clinical suspicion and
testing. In other countries, the case fatality rate is up to
21.9%,12 but in this study, most cases (96.8%) were mild and
approximately 75% had complete recovery. Low fatality and
severity were also reported in the study from Shanghai.9
Milder infection and lower incidence in this study and in
China may be explained by different and less pathogenic
circulating C. difficile strains in China compared with other
countries, as reported in previous Chinese studies.9,13,14
Investigation of the ribotypes of these strains is underway
for further characterization and to enable international
comparison.
Isolation precautions are recommended to prevent the
spread of CDI via direct and indirect contact.15 However, no
isolation precautions were performed for CDI cases in the
participating hospital, which presents potential risk of noso-
comial transmission of CDI. In addition, without proper anti-
bacterial treatment, nearly 85% of CDI cases could have served
as a reservoir for either nosocomial transmission during their
hospital stay or community transmission as they were dis-
charged with unresolved diarrhoea. There was a potential
delay in receiving specific therapy in the suspected but non-CDI
cases who were treated with metronidazole or vancomycin
alone.
In conclusion, this study has demonstrated that the inci-
dence of CDI in Shantou, China was lower compared with other
countries, and that lack of diagnostic testing for CDI was
associated with: (i) a significant number (26.4%) of patients
with watery diarrhoea (including 84.1% of CDI cases and 9.4% of
non-CDI cases) receiving improper management; (ii) risk of
nosocomial transmission from lack of isolation precautions; and
(iii) risk of community transmission due to symptomatic TCD
carriers.
Updating national and hospital practice guidelines in line
with the current evidence and implementing diagnostic testing
for CDI are recommended to avoid preventable consequences
of CDI in Chinese hospitals.Acknowledgements
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